Varaico: Literature-Extracted Genetic Variants

Gene:DMAC2L
Variant:p.P18L
Back to variants list

DMAC2L

NM_001382507.1:p.P18L

Associated Papers

Global profiling of N-terminal cysteine-dependent degradation mechanisms.

Bekturova A et al.

Proceedings of the National Academy of Sciences of the United States of America, 2025

40794836 (PubMed )
Supplement: pnas.2501681122.sd02.xlsx › Table_S2B

Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient.

Valentine H et al.

Cancer Research Communications, 2022

36643868 (PubMed )
Supplement: crc-22-0245-s07.xlsx › Variants_All_Exonic.exclude_ncR

Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.

Cukier HN et al.

Npj Parkinson's Disease, 2022

35768426 (PubMed )
Supplement: 41531_2022_346_MOESM2_ESM.xlsx › SupTab1

Renal oncocytoma characterized by the defective complex I of the respiratory chain boosts the synthesis of the ROS scavenger glutathione.

Kürschner G et al.

Oncotarget, 2017

29285300 (PubMed )
Supplement: oncotarget-08-105882-s002.xlsx › nuclear_gene_mutations

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response.

Lips EH et al.

Breast Cancer Research : Bcr, 2015

26433948 (PubMed )
Supplement: 13058_2015_642_MOESM4_ESM.xlsx › somatic_variants_proposal2.txt
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."